Shares of the Marlborough-based medical device giant (NYSE: BSX) were up 8 percent in after hour trading on the news, which brings closure to litigation which has been hanging over its head since its 2006 acquisition of Guidant.
J&J (NYSE: JNJ) claimed in the lawsuit that Guidant, for which Boston Scientific paid $27 billion, broke the terms of an earlier contract to be acquired by J&J by providing information to BSX. The New Jersey company claimed its damages from the failed merger were $4.35 billion plus interest, for a t...
22:53 LG Display reports record fourth quarter profit of $778 million18
21:52 Netflix nears 94 million subscribers 10 years after streaming launch21
16:50 Goldman Sachs, Citigroup earnings confirm Trump effect on banks19
11:20 PE firm Warburg buys $121 million stake in Indian cinema operator PVR16